Responses
Regular and young investigator award abstracts
Immune-stimulants and immune modulators
568 XTX201, a protein-engineered IL-2, exhibits tumor-selective activity in mice without peripheral toxicities in non-human primates
Compose a Response to This Article
Other responses
No responses have been published for this article.
